Working together to restore human health
The WTN is a Manitoba-based collaborative initiative designed by SciMar Ltd. to:
- study health through the breakthrough scientific understanding of “hepatic insulin-sensitizing substance (HISS)” (a hormone) and “nutrient partitioning” (a biological process);
- develop new tools and promote new strategies to prevent and treat type 2 diabetes; and
- create the conditions for dramatic improvements in individual and community well-being.
The WTN aims to inform and shape the strategic evolutions and the transformational leaps required to address the global type 2 diabetes epidemic and to enhance human health.
Through the WTN initiative, SciMar brings together like-minded communities, businesses, and organizations to explore, measure, and understand the specific impacts of a variety of health interventions.
The WTN aims to gather data from several hundred individual participants to inform research into hepatic insulin-sensitizing substance and nutrient partitioning, and to improve community health. (All data are digitized and anonymized. No individual will ever be identified. No data will ever be sold.)